Document Detail


Sequential ventilation/perfusion imaging of massive pulmonary embolism treated with recombinant tissue plasminogen activator.
MedLine Citation:
PMID:  2107996     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pulmonary embolism is a common clinical problem estimated to cause 200,000 deaths per year in the United State. There is increasing interest in early diagnosis and prompt aggressive therapy. A case is reported of a patient with massive pulmonary embolism treated with recombinant tissue plasminogen activator. Ventilation/perfusion imaging was used both to make an early diagnosis as well as to evaluate the efficacy of therapy.
Authors:
J Petronis
Related Documents :
14966076 - Massive pulmonary haemorrhage complicating the treatment of acute coronary syndrome.
6621846 - Fatal complication of the "bonnet bypass": case report.
3651276 - Massive intraoperative pulmonary embolism in a child.
7444046 - Control of massive hemoptysis by embolization of intercostal arteries.
8926196 - Aortic and iliac artery thrombosis in calves: nine cases (1974-1993).
6509906 - Carnitine ester hydrolysis in arteries from normal and cholesterol-fed rabbits and the ...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Clinical nuclear medicine     Volume:  15     ISSN:  0363-9762     ISO Abbreviation:  Clin Nucl Med     Publication Date:  1990 Mar 
Date Detail:
Created Date:  1990-05-09     Completed Date:  1990-05-09     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7611109     Medline TA:  Clin Nucl Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  150-3     Citation Subset:  IM    
Affiliation:
Division of Nuclear Medicine, Francis Scott Key Medical Center, Baltimore, Maryland 21224.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Humans
Lung / radionuclide imaging*
Male
Pulmonary Embolism / drug therapy,  radionuclide imaging*
Recombinant Proteins / therapeutic use
Tissue Plasminogen Activator / therapeutic use*
Ventilation-Perfusion Ratio*
Chemical
Reg. No./Substance:
0/Recombinant Proteins; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CO2 laser cauterization of giant-cell tumor margins.
Next Document:  Ifosfamide and mesna.